Patients with MuSK-Ab-positive MG showed better results despite having more severe worst conditions, which suggests that AChR-Ab-negative MG, excluding MuSK-Ab-positive MG, is distinct from other generalized MG subtypes from the perspective of response to therapy. The gene discussed is MUSK; the disease is myasthenia gravis.